{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:17Z","timestamp":1707525137735},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,20]]},"DOI":"10.7759\/cureus.39265","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:28:27Z","timestamp":1684603707000},"source":"Crossref","is-referenced-by-count":0,"title":["Association Between CYP2C19 Genotypes With Clinical Phenotypes and Adipokine Levels Among Ischemic Stroke Patients: A Prospective Observational Study"],"prefix":"10.7759","author":[{"given":"Jitender","family":"Gairolla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dheeraj","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phulen","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupinder","family":"Kler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bikash","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhu","family":"Khullar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Naithani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70031-5","article-title":"Preventing stroke: saving lives around the world","volume":"6","author":"Strong K","year":"2007","unstructured":"Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007, 6:182-7. 10.1016\/S1474-4422(07)70031-5","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2013.15.3.128","article-title":"Stroke epidemiology and stroke care services in India","volume":"15","author":"Pandian JD","year":"2013","unstructured":"Pandian JD, Sudhan P. Stroke epidemiology and stroke care services in India. J Stroke. 2013, 15:128-34. 10.5853\/jos.2013.15.3.128","journal-title":"J Stroke"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson TA","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, et al.. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107:499-511. 10.1161\/01.cir.0000052939.59093.45","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"Ross R","year":"1993","unstructured":"Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993, 362:801-9. 10.1038\/362801a0","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.108.179739","article-title":"Concept of vulnerable\/unstable plaque","volume":"30","author":"Finn AV","year":"2010","unstructured":"Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable\/unstable plaque. Arterioscler Thromb Vasc Biol. 2010, 30:1282-92. 10.1161\/ATVBAHA.108.179739","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2016-0055","article-title":"Leptin and adiponectin: pathophysiological role and possible therapeutic target of inflammation in ischemic stroke","volume":"28","author":"Gairolla J","year":"2017","unstructured":"Gairolla J, Kler R, Modi M, Khurana D. Leptin and adiponectin: pathophysiological role and possible therapeutic target of inflammation in ischemic stroke. Rev Neurosci. 2017, 28:295-306. 10.1515\/revneuro-2016-0055","journal-title":"Rev Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.759208","article-title":"Cytochrome P450-mediated metabolism in brain: functional roles and their implications","volume":"9","author":"Ravindranath V","year":"2013","unstructured":"Ravindranath V, Strobel HW. Cytochrome P450-mediated metabolism in brain: functional roles and their implications. Expert Opin Drug Metab Toxicol. 2013, 9:551-8. 10.1517\/17425255.2013.759208","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1021\/bi026842n","article-title":"Arachidonic acid-induced IL-6 expression is mediated by PKC alpha activation in osteoblastic cells","volume":"42","author":"Bordin L","year":"2003","unstructured":"Bordin L, Priante G, Musacchio E, Giunco S, Tibaldi E, Clari G, Baggio B. Arachidonic acid-induced IL-6 expression is mediated by PKC alpha activation in osteoblastic cells. Biochemistry. 2003, 42:4485-91. 10.1021\/bi026842n","journal-title":"Biochemistry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2006.05.012","article-title":"Polyunsaturated fatty acids and inflammation","volume":"75","author":"Calder PC","year":"2006","unstructured":"Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids. 2006, 75:197-202. 10.1016\/j.plefa.2006.05.012","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams HP Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993, 24:35-41. 10.1161\/01.str.24.1.35","journal-title":"Stroke"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2020.04.038","article-title":"Clopidogrel response in ischemic stroke patients: Is polymorphism or gender more important? Results of the CRISP study","volume":"76","author":"Gairolla J","year":"2020","unstructured":"Gairolla J, Ahluwalia J, Khullar M, et al.. Clopidogrel response in ischemic stroke patients: Is polymorphism or gender more important? Results of the CRISP study. J Clin Neurosci. 2020, 76:81-6. 10.1016\/j.jocn.2020.04.038","journal-title":"J Clin Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.105","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update","volume":"94","author":"Scott SA","year":"2013","unstructured":"Scott SA, Sangkuhl K, Stein CM, et al.. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther. 2013, 94:317-23. 10.1038\/clpt.2013.105","journal-title":"Clin Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-15-83","article-title":"Association between genetic polymorphisms of cytochrome P450 2C19 and the risk of cerebral ischemic stroke in Chinese","volume":"15","author":"Gu S","year":"2014","unstructured":"Gu S, Sun Y, Han R, Wang L, Wang D, Wang J, Li X. Association between genetic polymorphisms of cytochrome P450 2C19 and the risk of cerebral ischemic stroke in Chinese. BMC Med Genet. 2014, 15:83. 10.1186\/1471-2350-15-83","journal-title":"BMC Med Genet"},{"key":"ref14","article-title":"Cytochrome P450 1A1 (CYP1A1) T6325C polymorphism might modulate essential hypertension-associated stroke risk","volume":"23","author":"Lan\u00e7a V","year":"2004","unstructured":"Lan\u00e7a V, Alc\u00e2ntara P, Braz-Nogueira J, Bicho MP. Cytochrome P450 1A1 (CYP1A1) T6325C polymorphism might modulate essential hypertension-associated stroke risk. Rev Port Cardiol. 2004, 23:343-55.","journal-title":"Rev Port Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30409-1","article-title":"The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016","volume":"6","author":"India State-Level Disease Burden Initiative CRD Collaborators","year":"2018","unstructured":"India State-Level Disease Burden Initiative CRD Collaborators. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016. Lancet Glob Health. 2018, 6:e1363-74. 10.1016\/S2214-109X(18)30409-1","journal-title":"Lancet Glob Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-013-9508-6","article-title":"Role of inflammation and its mediators in acute ischemic stroke","volume":"6","author":"Jin R","year":"2013","unstructured":"Jin R, Liu L, Zhang S, Nanda A, Li G. Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Transl Res. 2013, 6:834-51. 10.1007\/s12265-013-9508-6","journal-title":"J Cardiovasc Transl Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-7-97","article-title":"Inflammatory mechanisms in ischemic stroke: therapeutic approaches","volume":"7","author":"Lakhan SE","year":"2009","unstructured":"Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med. 2009, 7:97. 10.1186\/1479-5876-7-97","journal-title":"J Transl Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI13143","article-title":"Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity","volume":"108","author":"Konstantinides S","year":"2001","unstructured":"Konstantinides S, Sch\u00e4fer K, Koschnick S, Loskutoff DJ. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest. 2001, 108:1533-40. 10.1172\/JCI13143","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2012.06.008","article-title":"Anti-inflammatory and anti-atherogenic properties of adiponectin","volume":"94","author":"Ohashi K","year":"2012","unstructured":"Ohashi K, Ouchi N, Matsuzawa Y. Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie. 2012, 94:2137-42. 10.1016\/j.biochi.2012.06.008","journal-title":"Biochimie"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/2042098617712657","article-title":"Pharmacogenetics and precision medicine: is inflammation a covert threat to effective genotype-based therapy?","volume":"8","author":"Shah RR","year":"2017","unstructured":"Shah RR. Pharmacogenetics and precision medicine: is inflammation a covert threat to effective genotype-based therapy?. Ther Adv Drug Saf. 2017, 8:267-72. 10.1177\/2042098617712657","journal-title":"Ther Adv Drug Saf"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.2007.00417.x","article-title":"Genetic polymorphism of CYP2C19 gene in the Stanislas cohort. A link with inflammation","volume":"72","author":"Bertrand-Thi\u00e9bault C","year":"2008","unstructured":"Bertrand-Thi\u00e9bault C, Berrahmoune H, Thompson A, et al.. Genetic polymorphism of CYP2C19 gene in the Stanislas cohort. A link with inflammation. Ann Hum Genet. 2008, 72:178-83. 10.1111\/j.1469-1809.2007.00417.x","journal-title":"Ann Hum Genet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00473.2016","article-title":"Association of CYP2C19 variants and epoxyeicosatrienoic acids on patients with microvascular angina","volume":"311","author":"Akasaka T","year":"2016","unstructured":"Akasaka T, Sueta D, Arima Y, et al.. Association of CYP2C19 variants and epoxyeicosatrienoic acids on patients with microvascular angina. Am J Physiol Heart Circ Physiol. 2016, 311:H1409-15. 10.1152\/ajpheart.00473.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.04.008","article-title":"Association between cytochrome P450 2C19 polymorphism and clinical outcomes in Chinese patients with coronary artery disease","volume":"220","author":"Chen M","year":"2012","unstructured":"Chen M, Liu XJ, Yan SD, et al.. Association between cytochrome P450 2C19 polymorphism and clinical outcomes in Chinese patients with coronary artery disease. Atherosclerosis. 2012, 220:168-71. 10.1016\/j.atherosclerosis.2011.04.008","journal-title":"Atherosclerosis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/132457-association-between-cyp2c19-genotypes-with-clinical-phenotypes-and-adipokine-levels-among-ischemic-stroke-patients-a-prospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:08Z","timestamp":1707508868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/132457-association-between-cyp2c19-genotypes-with-clinical-phenotypes-and-adipokine-levels-among-ischemic-stroke-patients-a-prospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.39265","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,20]]}}}